TPW 2.16 Clinical Predictors of Non-Resolution after Gastrografin Challenge in Adhesional Small Bowel Obstruction
British Journal of Surgery · 05.08.2026 · 113 (Supplement_8)
DOI: 10.1093/bjs/znag087.314 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2026. Verfasst von Andrew Chiagozie Ekwesianya und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Band adhesions remain the leading cause of small bowel obstruction (SBO) in adults. Non-operative management is the initial approach and succeeds in most cases. Gastrografin (Diatrizoate), a water-soluble contrast medium, aids resolution through its osmotic effect on the bowel. The aim of this study is to assess Gastrografin’s effectiveness and predictors of non-resolution in adhesional SBO.
Methods
This retrospective study, conducted at Mid and South Essex NHS Foundation Trust (January 2020–December 2024), included patients ≥ 16 years with CT-confirmed adhesional SBO who received 100 ml Gastrografin (orally or via nasogastric tube), followed by abdominal X-ray at 12 hours. Exclusions included non-adhesional causes of SBO, Gastrografin given only for diagnosis, contraindications to non-operative management, and incomplete data.
Results
A total of 271 patients (median age 74 years; 139 males, 132 females) were analysed. Median hospital stay was 10 days (range 0–159), with mean Charlson Comorbidity Index of 5.9. Adhesions were linked to prior colorectal surgery (41.0%), gynaecological surgery (10.7%), or no documented prior surgery (24.0%); 21.0% had previous SBO admissions. Contrast reached the colon in 59.4%, and clinical resolution occurred in 64.9%. Of 95 non-resolvers, 77.9% required surgery (26.3% with bowel resection). Only 10.5% of failures had prior SBO admissions, while 70.5% showed no colonic contrast at 12 hours.
Conclusions
Age, Charlson Comorbidity Index, and previous SBO admissions did not predict success. However, absence of contrast in the colon on X-ray 12 hours post-Gastrografin administration was a strong predictor of non-resolution and likely need for operative intervention.
Zitieren
APA
Ekwesianya, A. C., Abernethy, J., Ko, W., Faridi, H., Chan, W. Y., & Ayantunde, A. A. (2026). TPW 2.16 Clinical Predictors of Non-Resolution after Gastrografin Challenge in Adhesional Small Bowel Obstruction. British Journal of Surgery, 113(Supplement_8). https://doi.org/10.1093/bjs/znag087.314
Vancouver
Ekwesianya AC, Abernethy J, Ko W, Faridi H, Chan WY, Ayantunde AA. TPW 2.16 Clinical Predictors of Non-Resolution after Gastrografin Challenge in Adhesional Small Bowel Obstruction. British Journal of Surgery. 2026;113(Supplement_8). doi:10.1093/bjs/znag087.314
BibTeX
@article{Ekwesianya2026,
author = {Ekwesianya, Andrew Chiagozie and Abernethy, Jessie and Ko, Wan and Faridi, Hayah and Chan, Wing Yan and Ayantunde, Abraham Abiodun},
title = {TPW 2.16 Clinical Predictors of Non-Resolution after Gastrografin Challenge in Adhesional Small Bowel Obstruction},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_8},
doi = {10.1093/bjs/znag087.314}
}
EUVIMED